Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High Expression of CEMIP Correlates Poor Prognosis and the Tumur Microenvironment in Breast Cancer as a Promisingly Prognostic Biomarker

13 Dec 2021

Abstract excerpt

Cell migration-inducing hyaluronidase 1 (CEMIP), a Wnt-related protein and also known as KIAA1199, is implicated in the process of metastatic colonization in a variety of malignant tumors, including breast cancer (BC), which is one of the most frequently diagnosed tumors in women worldwide. In this study, multiple public databases, online analytical tools, and bioinformatics approaches were applied to explore the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Fibroblast Growth Factor Research
Share to Wnt/β-catenin signaling in development and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34966410
DOI: 10.3389/fgene.2021.768140

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High Expression of CEMIP Correlates Poor Prognosis and the Tumur Microenvironment in Breast Cancer as a Promisingly Prognostic BiomarkerPMID 34966410Read ↗

CEMIP as a potential biomarker and therapeutic target for breast cancer patientsSemantic proximity Read ↗

Analysis of genomics and immune infiltration patterns of epithelial-mesenchymal transition related to metastatic breast cancer to boneSemantic proximity Read ↗

OCRL is a novel prognostic biomarker and its association with immunoregulation in breast cancerSemantic proximity Read ↗

FREM1 Serves as a Novel Therapeutic Target in Breast Cancer through Basement Membrane-Based Prognostic Modeling with Integrated Bioinformatics and Experimental ValidationSemantic proximity Read ↗

CILP, a Putative Gene Associated With Immune Infiltration in Breast Cancer Brain MetastasesSemantic proximity Read ↗

Screening and verification of potential gene targets in the metastasis of breast cancer by bioinformatics analysis and immunohistochemistrySemantic proximity Read ↗

Multidimensional analysis to elucidate the possible mechanism of bone metastasis in breast cancerSemantic proximity Read ↗

KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challengesSemantic proximity Read ↗

Landscape Analysis of Matrix Metalloproteinases Unveils Key Prognostic Markers for Patients With Breast CancerSemantic proximity Read ↗

Prognostic Value of CMTM6 Expression in Breast CancerSemantic proximity Read ↗

MMP1 acts as an independent prognostic biomarker correlated with immune infiltration in breast cancerSemantic proximity Read ↗

Identification of biomarker associated with Trop2 in breast cancer: implication for targeted therapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.